Why Most Xarelto Lawsuit Fail

Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical organizations, such as the makers of Xarelto, have a duty to ensure that their drugs are reasonably protected for use - and failure to complete so may be grounds for compensation. Our lawyers are working challenging to acquire those hurt by the drug the compensation they are entitled to.

Whilst bleeding is really a frequent complication connected with anticoagulants, it has been alleged that Xarelto is much more dangerous than conventional blood thinners due to the fact no antidote exists to reverse its blood-thinning effects. This signifies that, inside the event of an emergency, individuals may be at danger for irreversible bleeding issues, which includes life-threatening internal and gastrointestinal hemorrhaging.

If you or a loved a single suffered a serious bleeding event following taking Xarelto, you may have legal recourse. For much more data, speak to us nowadays to possess your case reviewed, free of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for previous and future medical bills, lost wages, discomfort and suffering and, in situations of death, funeral costs. In addition, they are in search of punitive damages, which are usually awarded to punish the defendant and deter other businesses from acting similarly.
Why Are Lawsuits Being Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Since of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding inside the occasion of an emergency. Plaintiffs in the lawsuits allege serious and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a protected anticoagulant option.
Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user within the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto what is xarelto indicated for linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.

Visit this page for more information on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.